Eric Roche
Overview
Explore the profile of Eric Roche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
ODonoghue B, Roche E, Lyne J, Renwick L, Clarke M
Int J Soc Psychiatry
. 2023 May;
69(7):1617-1625.
PMID: 37211684
Background: Migration is a robust risk factor for developing a psychotic disorder, yet there is a paucity of research on the outcomes of migrants who develop a psychotic disorder. Identifying...
2.
Crowley P, Casey S, Kelleher E, Roche E, Behan C, Cannon M, et al.
Ir J Med Sci
. 2023 Apr;
192(4):1769-1770.
PMID: 37032395
No abstract available.
3.
ODonoghue B, Lyne J, Roche E, Mifsud N, Renwick L, Behan C, et al.
Psychol Med
. 2021 May;
53(2):468-475.
PMID: 34030746
Background: Migration is an established risk factor for developing a psychotic disorder in countries with a long history of migration. Less is known for countries with only a recent history...
4.
Roche E, OSullivan R, Gunawardena S, Cannon M, Lyne J
Early Interv Psychiatry
. 2019 Aug;
14(3):330-335.
PMID: 31368245
Aim: The initial onset of mental illness occurs most frequently in adolescence or early adulthood. In order to inform the development of mental health services tailored for youth, we sought...
5.
Behan C, Kennelly B, Roche E, Renwick L, Masterson S, Lyne J, et al.
Br J Psychiatry
. 2019 Jul;
217(3):484-490.
PMID: 31339083
Background: Early intervention in psychosis is a complex intervention, usually delivered in a specialist stand-alone setting, which aims to improve outcomes for people with psychosis. Previous studies have been criticised...
6.
Roche E, Clarke M, Browne S, Turner N, McTuige O, Kamali M, et al.
Ir J Psychol Med
. 2018 Oct;
27(1):15-18.
PMID: 30282289
Background: Reported rates of depression in schizophrenia vary considerably. Objective: To measure the prevalence of depression in a first episode sample of people with schizophrenia. Methods: All referrals with a...
7.
Das A, Datta S, Roche E, Chaffee S, Jose E, Shi L, et al.
Sci Rep
. 2018 Jan;
8(1):1696.
PMID: 29374192
Collagenases are useful in enzymatic wound debridement. Clostridial collagenase, marketed as Collagenase Santyl Ointment (CSO), is FDA approved for such use. Building on the scientific premise that collagenases as well...
8.
Negative symptoms of psychosis: A life course approach and implications for prevention and treatment
Lyne J, ODonoghue B, Roche E, Renwick L, Cannon M, Clarke M
Early Interv Psychiatry
. 2017 Oct;
12(4):561-571.
PMID: 29076240
Aim: Negative symptoms are a cause of enduring disability in serious mental illness. In spite of this, the development of effective treatments for negative symptoms has remained slow. The challenge...
9.
Renwick L, Owens L, Lyne J, ODonoghue B, Roche E, Drennan J, et al.
Int J Nurs Stud
. 2017 Sep;
76:28-35.
PMID: 28910597
Background: Diminished social networks are common in psychosis but few studies have measured these comprehensively and prospectively to determine how networks and support evolve during the early phase. There is...
10.
Ranieri V, Madigan K, Roche E, McGuinness D, Bainbridge E, Feeney L, et al.
BJPsych Bull
. 2017 Apr;
41(2):87-91.
PMID: 28400966
Caring for someone with a mental illness is increasingly occurring within the community. As a result, family members who fulfil a caregiving role may experience substantial levels of burden and...